Ftse Mib
33.553,83
-0,46%
DAX
18.138,34
-0,13%
S&P 500
5.469,30
0,39%
NASDAQ
17.717,65
0,00%
Bitcoin
61.432,30
-0,61%
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Germania TG Mithra Pharmaceuticals SA (1TM) Mithra Pharmaceuticals SA (1TM) Notizie

Mithra Pharmaceuticals SA

1TM
0,216
0,00 (0,00%)
02:00:00 - Dati in Tempo Reale
Borsa: Tradegate
Tipo: Azione Ordinaria
Valuta: EUR

Ultime notizie

Data Ora Fonte Titolo
08/3/202407:00GLOBEMithra reports full year 2023 financial results
05/3/202407:01GLOBEMithra announces changes to its executive management
05/3/202407:00GLOBEMithra initiates monetization process, receives bridge loan..
29/2/202411:42GLOBEDONESTA® safety study for menopause completes treatment..
15/2/202418:23GLOBEMithra sells shares in Mayne Pharma
06/2/202407:00GLOBEMithra updates on cash position
21/12/202317:45GLOBEMithra and Rafa Laboratories sign binding Head of Terms to..
20/12/202317:45GLOBEMithra Completes Pediatric Study of ESTELLE® in Adolescent..
18/12/202307:00GLOBEMithra Receives Positive DSMB Opinion on DONESTA® European..
04/12/202307:00GLOBEMithra and Gedeon Richter sign binding Head of Terms to..
30/11/202307:00GLOBEMithra receives guidance from the FDA for the DONESTA® NDA..
28/11/202317:45GLOBEMithra to hold five presentations on key role of estrogens..
07/11/202307:00GLOBEMithra’s NEXTSTELLIS® granted additional patent in the..
06/11/202318:52GLOBEMithra releases invitation to its extraordinary securities..
26/10/202307:00GLOBEMithra and Searchlight Pharma sign DONESTA® licensing..
23/10/202307:00GLOBEMithra to receive EUR 2.5 million milestone payment from..
17/10/202307:00GLOBEMithra’s Board of Directors to propose the removal of its..
11/10/202307:15GLOBEShareholder Letter
11/10/202307:00GLOBEMithra announces update to the agenda of its upcoming..
10/10/202318:00GLOBEMithra to Hold Presentations on Key Role of Estrogens in..
05/10/202307:00GLOBEMithra Provides an Update in the Context of Recent Market..
27/9/202307:00GLOBEMithra Announces Presentation of Positive Data on Estetrol..
26/9/202307:00GLOBEMithra Financial Results for First-Half 2023
22/9/202313:30GLOBEMithra présentera ses résultats financiers du premier..
21/9/202317:55GLOBEInformation on the total number of voting rights..
12/9/202317:45GLOBEPublication of a Transparency Notification Received from..
11/9/202307:30GLOBELetter to Shareholders and Corporate Update
Apertura: Min: Max:
Chiusura: 0,216

La tua Cronologia

TG
1TM
Mithra Pharmaceuticals
TSXV
AT
AcuityAds
LSE
0I7T
Serdica Properties Adsits
USOTC
SZCRF
Scor (PK)
BIT
P20DG2
NLBNPIT20DG2 20991231 12...
TSXV
CKR
Caribou King Resources Ltd.
NYSE
EXR
Extra Space Storage
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network